These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25389436)
1. The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Li S; Shi S; Chen F; Lin J Gastroenterol Res Pract; 2014; 2014():307805. PubMed ID: 25389436 [TBL] [Abstract][Full Text] [Related]
2. The Role of Baclofen in the Treatment of Gastroesophageal Reflux Disease. Warren RL; Davis SM J Pharm Technol; 2015 Dec; 31(6):258-261. PubMed ID: 34860946 [No Abstract] [Full Text] [Related]
3. Baclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials. Arabpour E; Khoshdel S; Akhgarzad A; Abdi M; Tabatabaie N; Alijanzadeh D; Abdehagh M Front Med (Lausanne); 2023; 10():997440. PubMed ID: 36873860 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Baclofen as Add-on Therapy for Refractory Gastroesophageal Reflux Disease: A Meta-analysis. Dong H; Luo Y; Liu D; Du X; Du H J Clin Gastroenterol; 2024 Jun; ():. PubMed ID: 38869961 [TBL] [Abstract][Full Text] [Related]
5. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog. Lehmann A; Hansson-Brändén L; Kärrberg L Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158 [TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors. Vakil NB; Huff FJ; Cundy KC Aliment Pharmacol Ther; 2013 Jul; 38(2):107-17. PubMed ID: 23721547 [TBL] [Abstract][Full Text] [Related]
7. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy? Beaumont H; Boeckxstaens GE Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837 [TBL] [Abstract][Full Text] [Related]
8. Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study. Curcic J; Schwizer A; Kaufman E; Forras-Kaufman Z; Banerjee S; Roy S; Pal A; Hebbard GS; Boesiger P; Fried M; Steingoetter A; Schwizer W; Fox M Aliment Pharmacol Ther; 2014 Nov; 40(10):1230-40. PubMed ID: 25230154 [TBL] [Abstract][Full Text] [Related]
9. Novel treatments of GERD: focus on the lower esophageal sphincter. Lehmann A Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449 [TBL] [Abstract][Full Text] [Related]
10. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms. Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138 [TBL] [Abstract][Full Text] [Related]
11. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. van Herwaarden MA; Samsom M; Rydholm H; Smout AJ Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845 [TBL] [Abstract][Full Text] [Related]
12. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
13. Transient lower esophageal sphincter relaxations and gastroesophageal reflux episodes in healthy subjects and GERD patients during 24 hours. Grossi L; Ciccaglione AF; Travaglini N; Marzio L Dig Dis Sci; 2001 Apr; 46(4):815-21. PubMed ID: 11330418 [TBL] [Abstract][Full Text] [Related]
14. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Lidums I; Lehmann A; Checklin H; Dent J; Holloway RH Gastroenterology; 2000 Jan; 118(1):7-13. PubMed ID: 10611148 [TBL] [Abstract][Full Text] [Related]
15. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. Kawai M; Kawahara H; Hirayama S; Yoshimura N; Ida S J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):317-23. PubMed ID: 15076634 [TBL] [Abstract][Full Text] [Related]
16. LINX Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382 [TBL] [Abstract][Full Text] [Related]
17. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study. Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Hou M; Hu H; Jin C; Yu X Iran J Public Health; 2020 Dec; 49(12):2264-2274. PubMed ID: 34178733 [TBL] [Abstract][Full Text] [Related]
19. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Lipka S; Kumar A; Richter JE Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1058-67.e1. PubMed ID: 25459556 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]